Why the drugmaker behind a pancreatic cancer breakthrough stayed independent
- Posted on August 28, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
Why the drugmaker behind a pancreatic cancer breakthrough stayed independent
Revolution Medicines attracted takeover interest but decided to go it alone. This week’s FDA approval of its pancreatic cancer pill is the payoff.
